Adi Barzel, PhD is the President of the Israeli Society of Gene and Cell Therapy, Head of the Dotan Center for Advanced Therapies at the Tel Aviv Sourasky Medical Center and a senior lecturer in the School of Neurobiology, Biochemistry and Biophysics at Tel Aviv University. Adi Barzel a co-founder of LogicBio Therapeutics, a clinical-stage NASDAQ traded gene therapy company developing transformational medicines for congenital disorders, and he is a co-founder of Tabby Therapeutics, pioneering B cell engineering for immune-oncology.